This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monath, T. P.
Right arrow Articles by Guirakhoo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monath, T. P.
Right arrow Articles by Guirakhoo, F.

 Previous Article  |  Next Article 

Journal of Virology, February 2002, p. 1932-1943, Vol. 76, No. 4
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.4.1932-1943.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines

Thomas P. Monath,1* Juan Arroyo,1 Inessa Levenbook,2 Zhen-Xi Zhang,1 John Catalan,1 Ken Draper,3 and Farshad Guirakhoo1

Acambis Inc., Cambridge, Massachusetts 02139,1 Northbrook, Illinois 60062 ,2 Sierra Biomedical Inc., Sparks, Nevada 894313

Received 16 August 2001/ Accepted 6 November 2001

A chimeric yellow fever (YF) virus/Japanese encephalitis (JE) virus vaccine (ChimeriVax-JE) was constructed by insertion of the prM-E genes from the attenuated JE virus SA14-14-2 vaccine strain into a full-length cDNA clone of YF 17D virus. Passage in fetal rhesus lung (FRhL) cells led to the emergence of a small-plaque virus containing a single Met->Lys amino acid mutation at E279, reverting this residue from the SA14-14-2 to the wild-type amino acid. A similar virus was also constructed by site-directed mutagenesis (J. Arroyo, F. Guirakhoo, S. Fenner, Z.-X. Zhang, T. P. Monath, and T. J. Chambers, J. Virol. 75:934-942, 2001). The E279 mutation is located in a beta-sheet in the hinge region of the E protein that is responsible for a pH-dependent conformational change during virus penetration from the endosome into the cytoplasm of the infected cell. In independent transfection-passage studies with FRhL or Vero cells, mutations appeared most frequently in hinge 4 (bounded by amino acids E266 to E284), reflecting genomic instability in this functionally important region. The E279 reversion caused a significant increase in neurovirulence as determined by the 50% lethal dose and survival distribution in suckling mice and by histopathology in rhesus monkeys. Based on sensitivity and comparability of results with those for monkeys, the suckling mouse is an appropriate host for safety testing of flavivirus vaccine candidates for neurotropism. After intracerebral inoculation, the E279 Lys virus was restricted with respect to extraneural replication in monkeys, as viremia and antibody levels (markers of viscerotropism) were significantly reduced compared to those for the E279 Met virus. These results are consistent with the observation that empirically derived vaccines developed by mouse brain passage of dengue and YF viruses have increased neurovirulence for mice but reduced viscerotropism for humans.

* Corresponding author. Mailing address: Acambis Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 494-1339. Fax: (617) 494-1741. E-mail: tom.monath{at}acambis.com.

Journal of Virology, February 2002, p. 1932-1943, Vol. 76, No. 4
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.4.1932-1943.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Levenbook, I., Draper, K., Maximova, O. A., Whitehead, S. S., Murphy, B. R., Pletnev, A. G. (2009). Neuropathogenesis and Neurovirulence of Live Flaviviral Vaccines in Monkeys. J. Virol. 83: 5289-5292 [Full Text]  
  • Maximova, O. A., Ward, J. M., Asher, D. M., St. Claire, M., Finneyfrock, B. W., Speicher, J. M., Murphy, B. R., Pletnev, A. G. (2008). Comparative Neuropathogenesis and Neurovirulence of Attenuated Flaviviruses in Nonhuman Primates. J. Virol. 82: 5255-5268 [Abstract] [Full Text]  
  • Julander, J. G., Furuta, Y., Shafer, K., Sidwell, R. W. (2007). Activity of T-1106 in a Hamster Model of Yellow Fever Virus Infection. Antimicrob. Agents Chemother. 51: 1962-1966 [Abstract] [Full Text]  
  • Zhao, Z., Date, T., Li, Y., Kato, T., Miyamoto, M., Yasui, K., Wakita, T. (2005). Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. J. Gen. Virol. 86: 2209-2220 [Abstract] [Full Text]  
  • Arroyo, J., Miller, C., Catalan, J., Myers, G. A., Ratterree, M. S., Trent, D. W., Monath, T. P. (2004). ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy. J. Virol. 78: 12497-12507 [Abstract] [Full Text]  
  • Chu, J. J. H., Ng, M. L. (2004). Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway. J. Virol. 78: 10543-10555 [Abstract] [Full Text]  
  • EBEL, G. D., CARRICABURU, J., YOUNG, D., BERNARD, K. A., KRAMER, L. D. (2004). GENETIC AND PHENOTYPIC VARIATION OF WEST NILE VIRUS IN NEW YORK, 2000-2003. Am J Trop Med Hyg 71: 493-500 [Abstract] [Full Text]  
  • Guirakhoo, F., Zhang, Z., Myers, G., Johnson, B. W., Pugachev, K., Nichols, R., Brown, N., Levenbook, I., Draper, K., Cyrek, S., Lang, J., Fournier, C., Barrere, B., Delagrave, S., Monath, T. P. (2004). A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys. J. Virol. 78: 9998-10008 [Abstract] [Full Text]  
  • Guirakhoo, F., Pugachev, K., Zhang, Z., Myers, G., Levenbook, I., Draper, K., Lang, J., Ocran, S., Mitchell, F., Parsons, M., Brown, N., Brandler, S., Fournier, C., Barrere, B., Rizvi, F., Travassos, A., Nichols, R., Trent, D., Monath, T. (2004). Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates. J. Virol. 78: 4761-4775 [Abstract] [Full Text]  
  • Hayasaka, D., Gritsun, T. S., Yoshii, K., Ueki, T., Goto, A., Mizutani, T., Kariwa, H., Iwasaki, T., Gould, E. A., Takashima, I. (2004). Amino acid changes responsible for attenuation of virus neurovirulence in an infectious cDNA clone of the Oshima strain of Tick-borne encephalitis virus. J. Gen. Virol. 85: 1007-1018 [Abstract] [Full Text]  
  • Modis, Y., Ogata, S., Clements, D., Harrison, S. C. (2003). A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 100: 6986-6991 [Abstract] [Full Text]  
  • McArthur, M. A., Suderman, M. T., Mutebi, J.-P., Xiao, S.-Y., Barrett, A. D. T. (2002). Molecular Characterization of a Hamster Viscerotropic Strain of Yellow Fever Virus. J. Virol. 77: 1462-1468 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»